Wed, Oct 22, 2014, 9:58 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Array BioPharma, Inc. Message Board

  • libtardbarry libtardbarry Mar 3, 2014 9:36 AM Flag

    Sweet news,

    couldn't be better..

    C L

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • About Asthma

      It is estimated that approximately 25 million people in the United States have asthma causing significant morbidity and mortality. The worldwide estimates are between 235-300 million people with 180,000 deaths annually. Despite the range of available asthma treatments, there remains a significant need for a convenient, safe and effective therapy for patients. Specifically, oral medications may provide improved adherence relative to inhaled and injectable therapies.
      Time for you short-selling skum to cover and hit the road.

      C L

      • 1 Reply to libtardbarry
      • Ron Squarer, Chief Executive Officer of Array, noted, "With many asthma patients poorly controlled on currently available therapies, especially among severe asthmatics, an oral drug targeting a novel anti-inflammatory mechanism may present an important new option for millions of patients. We are seeking an appropriate partner to develop ARRY-502 to its full potential."
        Oh yeah, big money on the way.

        C L

3.37-0.11(-3.16%)Oct 22 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Yelp, Inc.
NYSEWed, Oct 22, 2014 4:00 PM EDT
NXP Semiconductors NV
NasdaqGSWed, Oct 22, 2014 4:00 PM EDT
Cree, Inc.
NasdaqGSWed, Oct 22, 2014 4:00 PM EDT